New scientific claims suggest that semaglutide could reduce all-cause mortality by an astounding 25%
Weight loss medications carry risks and potential side effects
The skyrocketing cost of weight-loss drugs has state Medicaid programs looking for a solution Read full article: The skyrocketing cost of weight-loss drugs has state Medicaid programs looking for a solution Some of the more than a dozen states that cover the high cost of GLP-1 drugs like Wegovy, Ozempic and Zepbound through Medicaid or state employee insurance programs are scrambling to lessen the budgetary squeeze from fast-rising costs
UFs Sheer, also a UF College of Medicine professor who is the program director for the Obesity Medicine Fellowship at UF Health, was part of a research team that published a study in the Journal of the American Medical Heart Association, showing that patients with auto-immune diseases who took GLP-1s had fewer life-threatening blood clot blockages, lower emergency department use, and decreased mortality
All content was carefully reviewed, verified, and edited by the authors, who take full responsibility for the work
